2m 2m 2m 2m 2m 2m 2m
ABEONA THERAP (ABEO)
NASDAQ
$4.45-$0.06 (-1.24%)
Price as of Oct 22, 2026 7:55 PM EDT- $257.9MMarket Cap
- -16.64%1-Year Change
- BiotechnologyIndustry
ABEONA THERAP (ABEO)
$4.45-$0.06 (-1.24%)
ABEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.51 | ||
Change | -$0.09 (-1.96%) | ||
Open | $4.62 | ||
High | $4.67 | ||
Low | $4.50 | ||
Previous Close | $4.60 | ||
Volume | 643,557 | ||
30-Day Average Volume | 1,172,001 | ||
1-Week Change | 3.44% | ||
1-Month Change | -20.46% | ||
1-Year Change | -16.64% | ||
3-Year Change | 8.94% | ||
5-Year Change | -80.04% | ||
Fundamentals | |||
Shares Outstanding | 57.2M | ||
Total Assets | $179.5M | ||
Market Cap | $257.9M | ||
Enterprise Value | $216.7M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$20.2M | ||
Free Cash Flow | -$18.0M | ||
EBIT | -$19.6M | ||
EBITDA | -$18.9M | ||
Net Working Capital | $139.8M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 160 | ||
P/B | 2 | ||
P/E | -13 | ||
PEG | 1 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 07/05/2022 | ||
Earnings & Revenue